Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1983 Apr;40(1):190–197. doi: 10.1128/iai.40.1.190-197.1983

HLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans.

M Yasukawa, T Shiroguchi, Y Kobayashi
PMCID: PMC264835  PMID: 6187690

Abstract

Cytotoxic T lymphocytes (CTL) against herpes simplex virus (HSV) were induced in vitro from human peripheral blood lymphocytes by stimulation with HSV antigen. CTL generated by HSV type 1 (HSV-1) antigen stimulation killed not only HSV-1-infected target cells but also HSV type 2 (HSV-2)-infected target cells, though at a lower level. This evidence suggests that CTL against HSV recognize the HSV type-specific and type-common determinants on HSV-infected target cells. These CTL were generated from high responders against HSV-1 antigen as measured by antigen-specific T lymphocyte proliferation in vitro, but not to such an efficient degree from low responders. The cytotoxic activities of CTL against the allogeneic HSV-infected target cells were high when at least one of the HLA-A or -B antigens was shared. However, the HLA-A and -B nonidentical target cells were not killed effectively. The data presented here suggest the possibility of HLA restriction of HSV-specific CTL in humans.

Full text

PDF
190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergholtz B. O., Thorsby E. Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol. 1977;6(8):779–786. doi: 10.1111/j.1365-3083.1977.tb02151.x. [DOI] [PubMed] [Google Scholar]
  2. Biddison W. E., Krangel M. S., Strominger J. L., Ward F. E., Shearer G. M., Shaw S. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum Immunol. 1980 Oct;1(3):225–232. doi: 10.1016/0198-8859(80)90017-8. [DOI] [PubMed] [Google Scholar]
  3. Dickmeiss E., Soeberg B., Svejgaard A. Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature. 1977 Dec 8;270(5637):526–528. doi: 10.1038/270526a0. [DOI] [PubMed] [Google Scholar]
  4. Doherty P. C., Blanden R. V., Zinkernagel R. M. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev. 1976;29:89–124. doi: 10.1111/j.1600-065x.1976.tb00198.x. [DOI] [PubMed] [Google Scholar]
  5. Eberle R., Russell R. G., Rouse B. T. Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations. Infect Immun. 1981 Dec;34(3):795–803. doi: 10.1128/iai.34.3.795-803.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Engleman E. G., McMichael A. J., Batey M. E., McDevitt H. O. A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J Exp Med. 1978 Jan 1;147(1):137–146. doi: 10.1084/jem.147.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fukukawa T., Hirano T., Sakaguchi N., Teranishi T., Tsuyuguchi I., Nagao N., Naito N., Yoshimura K., Okubo Y., Tohda H. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line. J Immunol. 1981 May;126(5):1697–1701. [PubMed] [Google Scholar]
  8. Goulmy E., Termijtelen A., Bradley B. A., van Rood J. J. Y-antigen killing by T cells of women is restricted by HLA. Nature. 1977 Apr 7;266(5602):544–545. doi: 10.1038/266544a0. [DOI] [PubMed] [Google Scholar]
  9. Lawman M. J., Courtney R. J., Eberle R., Schaffer P. A., O'Hara M. K., Rouse B. T. Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun. 1980 Nov;30(2):451–461. doi: 10.1128/iai.30.2.451-461.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McMichael A. J., Parham P., Brodsky F. M., Pilch J. R. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies. J Exp Med. 1980 Aug 1;152(2 Pt 2):195s–203s. [PubMed] [Google Scholar]
  11. McMichael A. J., Ting A., Zweerink H. J., Askonas B. A. HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature. 1977 Dec 8;270(5637):524–526. doi: 10.1038/270524a0. [DOI] [PubMed] [Google Scholar]
  12. McMichael A. HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2. J Exp Med. 1978 Dec 1;148(6):1458–1467. doi: 10.1084/jem.148.6.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mori R., Tasaki T., Kimura G., Takeya K. Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice. Arch Gesamte Virusforsch. 1967;21(3):459–462. doi: 10.1007/BF01241745. [DOI] [PubMed] [Google Scholar]
  14. Moss D. J., Wallace L. E., Rickinson A. B., Epstein M. A. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro. Eur J Immunol. 1981 Sep;11(9):686–693. doi: 10.1002/eji.1830110904. [DOI] [PubMed] [Google Scholar]
  15. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 3. N Engl J Med. 1973 Oct 11;289(15):781–789. doi: 10.1056/NEJM197310112891505. [DOI] [PubMed] [Google Scholar]
  16. Pereira L., Dondero D. V., Gallo D., Devlin V., Woodie J. D. Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun. 1982 Jan;35(1):363–367. doi: 10.1128/iai.35.1.363-367.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pfizenmaier K., Jung H., Starzinski-Powitz A., Röllinghoff M., Wagner H. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. J Immunol. 1977 Sep;119(3):939–944. [PubMed] [Google Scholar]
  18. Pfizenmaier K., Starzinski-Powitz A., Röllinghoff M., Falks D., Wagner H. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature. 1977 Feb 17;265(5595):630–632. doi: 10.1038/265630a0. [DOI] [PubMed] [Google Scholar]
  19. Rager-Zisman B., Allison A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol. 1976 Jan;116(1):35–40. [PubMed] [Google Scholar]
  20. Rickinson A. B., Wallace L. E., Epstein M. A. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature. 1980 Feb 28;283(5750):865–867. doi: 10.1038/283865a0. [DOI] [PubMed] [Google Scholar]
  21. Russell A. S., Schlaut J. Association of HLA-A1 antigen and susceptibility to recurrent cold sores. Arch Dermatol. 1977 Dec;113(12):1721–1722. [PubMed] [Google Scholar]
  22. Sasazuki T., Kaneoka H., Nishimura Y., Kaneoka R., Hayama M., Ohkuni H. An HLA-linked immune suppression gene in man. J Exp Med. 1980 Aug 1;152(2 Pt 2):297s–313s. [PubMed] [Google Scholar]
  23. Sasazuki T., Kohno Y., Iwamoto I., Tanimura M., Naito S. Association between an HLA haplotype and low responsiveness to tetanus toxoid in man. Nature. 1978 Mar 23;272(5651):359–361. doi: 10.1038/272359b0. [DOI] [PubMed] [Google Scholar]
  24. Sethi K. K., Stroehmann I., Brandis H. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis. Nature. 1980 Aug 14;286(5774):718–720. doi: 10.1038/286718a0. [DOI] [PubMed] [Google Scholar]
  25. Sethi K. K., Wolff M. H. The nature of host-cell herpes-simplex virus interactions(s) that renders cells susceptible to virus-specific cytotoxic T cells. Immunobiology. 1980 Dec;157(4-5):365–378. doi: 10.1016/s0171-2985(80)80006-4. [DOI] [PubMed] [Google Scholar]
  26. Shaw S., Biddison W. E. HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus. J Exp Med. 1979 Mar 1;149(3):565–575. doi: 10.1084/jem.149.3.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sonoda S., Schlamowitz M. Studies of 125I trace labeling of immunoglobulin G by chloramine-T. Immunochemistry. 1970 Nov;7(11):885–898. doi: 10.1016/0019-2791(70)90051-0. [DOI] [PubMed] [Google Scholar]
  28. Tanaka Y., Sugamura K., Hinuma Y. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus. J Immunol. 1982 Mar;128(3):1241–1245. [PubMed] [Google Scholar]
  29. Wallace L. E., Moss D. J., Rickinson A. B., McMichael A. J., Epstein M. A. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants. Eur J Immunol. 1981 Sep;11(9):694–699. doi: 10.1002/eji.1830110905. [DOI] [PubMed] [Google Scholar]
  30. Weiner M. S., Bianco C., Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec;42(6):939–946. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES